Table 3.
Route | Exposure dose | Attack rate* |
---|---|---|
Aerosol | 24 μg† | 6/7 (86 %) |
IN | 100 μg‡ | 2/9 (22 %) |
Oral | 100 μg§ | 0/10 (0 %) |
*No. affected/no. total (% positive).
†4 min aerosol of 5 % (w/v) homogenate.
‡10 μl of 10 % (w/v) homogenate.
§100 μl of 1 % (w/v) homogenate.